世界の原核組み換え型タンパク質市場予測（～2028年）：ホルモン、インターフェロン、インターロイキン、その他

• 英文タイトル：Global Prokaryotic Recombinant Protein Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

• レポートコード：GIR-22E8326 • 出版社/出版日：GlobalInfoResearch / 2022年5月 • レポート形態：英文、PDF、100ページ • 納品方法：Eメール（2~3営業日） • 産業分類：医療機器

• 販売価格（消費税別）

Single User	￥522,000 (USD3,480)	▷ お問い合わせ
Multi User	￥783,000 (USD5,220)	▷ お問い合わせ
Corporate User	￥1,044,000 (USD6,960)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

原核組み換え型タンパク質市場レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。 GlobalInfoResearchの最新の調査によると、世界の原核組み換え型タンパク質の市場規模は2021年のxxx米ドルから2028年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。 原核組み換え型タンパク質市場は種類と用途によって区分されます。2017年～2028年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。 種類別セグメントは次をカバーします。 ・ホルモン、インターフェロン、インターロイキン、その他 用途別セグメントは次のように区分されます。 ・バイオテクノロジー企業、研究機関、委託研究機関、病院、研究所、その他 世界の原核組み換え型タンパク質市場の主要な市場プレーヤーは以下のとおりです。 ・Eli Lilly and Company、Merck、Roche、Prospec-Tany Technogene、Cusabio Technology、Randox Laboratories、Batavia Biosciences、Geno Technology、Kaneka and Eurogentec、Abnova Corporation、Cayman Chemical Company、Geltor IndieBio、Bioclone 地域別セグメントは次の地域・国をカバーします。 ・北米（米国、カナダ、メキシコ） ・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア） ・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア） ・南アメリカ（ブラジル、アルゼンチン、コロンビア） ・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ） 本調査レポートの内容は計15章あります。 ・第1章では、原核組み換え型タンパク質製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。 ・第2章では、主要な原核組み換え型タンパク質メーカーの企業概要、2019年～2022年までの原核組み換え型タンパク質の価格、販売量、売上、市場シェアを掲載しています。 ・第3章では、主要な原核組み換え型タンパク質メーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。 ・第4章では、2017年～2028年までの地域別原核組み換え型タンパク質の販売量、売上、成長性を示しています。 ・第5、6章では、2017年～2028年までの原核組み換え型タンパク質の種類別と用途別の市場規模、市場シェアと成長率を掲載しています。 ・第7、8、9、10、11章では、2017年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2028年までの主要地域での原核組み換え型タンパク質市場予測を収録しています。 ・第12章では、主要な原材料、主要なサプライヤー、および原核組み換え型タンパク質の産業チェーンを掲載しています。 ・第13、14、15章では、原核組み換え型タンパク質の販売チャネル、販売業者、顧客、調査結果と結論、付録、データソースなどについて説明します。 ***** 目次(一部) ***** ・市場概要 ・メーカー情報（企業概要、製品概要、販売量、価格、売上）：Eli Lilly and Company、Merck、Roche、Prospec-Tany Technogene、Cusabio Technology、Randox Laboratories、Batavia Biosciences、Geno Technology、Kaneka and Eurogentec、Abnova Corporation、Cayman Chemical Company、Geltor IndieBio、Bioclone ・メーカー別市場シェア ・地域別市場分析2017年-2028年 ・種類別分析2017年-2028年：ホルモン、インターフェロン、インターロイキン、その他 ・用途別分析2017年-2028年：バイオテクノロジー企業、研究機関、委託研究機関、病院、研究所、その他 ・原核組み換え型タンパク質の北米市場規模2017年-2028年：アメリカ、カナダ、メキシコ ・原核組み換え型タンパク質のヨーロッパ市場規模2017年-2028年：ドイツ、イギリス、フランス、ロシア、イタリア ・原核組み換え型タンパク質のアジア市場規模2017年-2028年：中国、日本、韓国、インド、東南アジア、オーストラリア ・原核組み換え型タンパク質の南米市場規模2017年-2028年：ブラジル、アルゼンチン ・原核組み換え型タンパク質の中東・アフリカ市場規模2017年-2028年：サウジアラビア、トルコ、エジプト、南アフリカ ・原材料および産業チェーン ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論

The Prokaryotic Recombinant Protein market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Prokaryotic Recombinant Protein market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Biotechnology Companies accounting for % of the Prokaryotic Recombinant Protein global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Hormones segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Prokaryotic Recombinant Protein include Eli Lilly and Company, Merck, Roche, Prospec-Tany Technogene, and Cusabio Technology, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Prokaryotic Recombinant Protein market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Hormones
Interferons
Interleukins
Others
Market segment by Application can be divided into
Biotechnology Companies
Research institutes
Contract Research organizations
Hospital
Laboratories
Others
The key market players for global Prokaryotic Recombinant Protein market are listed below:
Eli Lilly and Company
Merck
Roche
Prospec-Tany Technogene
Cusabio Technology
Randox Laboratories
Batavia Biosciences
Geno Technology
Kaneka and Eurogentec
Abnova Corporation
Cayman Chemical Company
Geltor IndieBio
Bioclone
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Prokaryotic Recombinant Protein product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Prokaryotic Recombinant Protein, with price, sales, revenue and global market share of Prokaryotic Recombinant Protein from 2019 to 2022.
Chapter 3, the Prokaryotic Recombinant Protein competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Prokaryotic Recombinant Protein breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Prokaryotic Recombinant Protein market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Prokaryotic Recombinant Protein.
Chapter 13, 14, and 15, to describe Prokaryotic Recombinant Protein sales channel, distributors, customers, research findings and conclusion, appendix and data source.

レポート目次

---

1 Market Overview
1.1 Prokaryotic Recombinant Protein Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Prokaryotic Recombinant Protein Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 Hormones
1.2.3 Interferons
1.2.4 Interleukins
1.2.5 Others
1.3 Market Analysis by Application
1.3.1 Overview: Global Prokaryotic Recombinant Protein Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Biotechnology Companies
1.3.3 Research institutes
1.3.4 Contract Research organizations
1.3.5 Hospital
1.3.6 Laboratories
1.3.7 Others
1.4 Global Prokaryotic Recombinant Protein Market Size & Forecast
1.4.1 Global Prokaryotic Recombinant Protein Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Prokaryotic Recombinant Protein Sales in Volume (2017-2028)
1.4.3 Global Prokaryotic Recombinant Protein Price (2017-2028)
1.5 Global Prokaryotic Recombinant Protein Production Capacity Analysis
1.5.1 Global Prokaryotic Recombinant Protein Total Production Capacity (2017-2028)
1.5.2 Global Prokaryotic Recombinant Protein Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Prokaryotic Recombinant Protein Market Drivers
1.6.2 Prokaryotic Recombinant Protein Market Restraints
1.6.3 Prokaryotic Recombinant Protein Trends Analysis
2 Manufacturers Profiles
2.1 Eli Lilly and Company
2.1.1 Eli Lilly and Company Details
2.1.2 Eli Lilly and Company Major Business
2.1.3 Eli Lilly and Company Prokaryotic Recombinant Protein Product and Services
2.1.4 Eli Lilly and Company Prokaryotic Recombinant Protein Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 Merck
2.2.1 Merck Details
2.2.2 Merck Major Business
2.2.3 Merck Prokaryotic Recombinant Protein Product and Services
2.2.4 Merck Prokaryotic Recombinant Protein Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 Roche
2.3.1 Roche Details
2.3.2 Roche Major Business
2.3.3 Roche Prokaryotic Recombinant Protein Product and Services
2.3.4 Roche Prokaryotic Recombinant Protein Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 Prospec-Tany Technogene
2.4.1 Prospec-Tany Technogene Details
2.4.2 Prospec-Tany Technogene Major Business
2.4.3 Prospec-Tany Technogene Prokaryotic Recombinant Protein Product and Services
2.4.4 Prospec-Tany Technogene Prokaryotic Recombinant Protein Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 Cusabio Technology
2.5.1 Cusabio Technology Details
2.5.2 Cusabio Technology Major Business
2.5.3 Cusabio Technology Prokaryotic Recombinant Protein Product and Services
2.5.4 Cusabio Technology Prokaryotic Recombinant Protein Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 Randox Laboratories
2.6.1 Randox Laboratories Details
2.6.2 Randox Laboratories Major Business
2.6.3 Randox Laboratories Prokaryotic Recombinant Protein Product and Services
2.6.4 Randox Laboratories Prokaryotic Recombinant Protein Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 Batavia Biosciences
2.7.1 Batavia Biosciences Details
2.7.2 Batavia Biosciences Major Business
2.7.3 Batavia Biosciences Prokaryotic Recombinant Protein Product and Services
2.7.4 Batavia Biosciences Prokaryotic Recombinant Protein Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8 Geno Technology
2.8.1 Geno Technology Details
2.8.2 Geno Technology Major Business
2.8.3 Geno Technology Prokaryotic Recombinant Protein Product and Services
2.8.4 Geno Technology Prokaryotic Recombinant Protein Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9 Kaneka and Eurogentec
2.9.1 Kaneka and Eurogentec Details
2.9.2 Kaneka and Eurogentec Major Business
2.9.3 Kaneka and Eurogentec Prokaryotic Recombinant Protein Product and Services
2.9.4 Kaneka and Eurogentec Prokaryotic Recombinant Protein Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10 Abnova Corporation
2.10.1 Abnova Corporation Details
2.10.2 Abnova Corporation Major Business
2.10.3 Abnova Corporation Prokaryotic Recombinant Protein Product and Services
2.10.4 Abnova Corporation Prokaryotic Recombinant Protein Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.11 Cayman Chemical Company
2.11.1 Cayman Chemical Company Details
2.11.2 Cayman Chemical Company Major Business
2.11.3 Cayman Chemical Company Prokaryotic Recombinant Protein Product and Services
2.11.4 Cayman Chemical Company Prokaryotic Recombinant Protein Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.12 Geltor IndieBio
2.12.1 Geltor IndieBio Details
2.12.2 Geltor IndieBio Major Business
2.12.3 Geltor IndieBio Prokaryotic Recombinant Protein Product and Services
2.12.4 Geltor IndieBio Prokaryotic Recombinant Protein Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.13 Bioclone
2.13.1 Bioclone Details
2.13.2 Bioclone Major Business
2.13.3 Bioclone Prokaryotic Recombinant Protein Product and Services
2.13.4 Bioclone Prokaryotic Recombinant Protein Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Prokaryotic Recombinant Protein Breakdown Data by Manufacturer
3.1 Global Prokaryotic Recombinant Protein Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Prokaryotic Recombinant Protein Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Prokaryotic Recombinant Protein
3.4 Market Concentration Rate
3.4.1 Top 3 Prokaryotic Recombinant Protein Manufacturer Market Share in 2021
3.4.2 Top 6 Prokaryotic Recombinant Protein Manufacturer Market Share in 2021
3.5 Global Prokaryotic Recombinant Protein Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Prokaryotic Recombinant Protein Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Prokaryotic Recombinant Protein Market Size by Region
4.1.1 Global Prokaryotic Recombinant Protein Sales in Volume by Region (2017-2028)
4.1.2 Global Prokaryotic Recombinant Protein Revenue by Region (2017-2028)
4.2 North America Prokaryotic Recombinant Protein Revenue (2017-2028)
4.3 Europe Prokaryotic Recombinant Protein Revenue (2017-2028)
4.4 Asia-Pacific Prokaryotic Recombinant Protein Revenue (2017-2028)
4.5 South America Prokaryotic Recombinant Protein Revenue (2017-2028)
4.6 Middle East and Africa Prokaryotic Recombinant Protein Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Prokaryotic Recombinant Protein Sales in Volume by Type (2017-2028)
5.2 Global Prokaryotic Recombinant Protein Revenue by Type (2017-2028)
5.3 Global Prokaryotic Recombinant Protein Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Prokaryotic Recombinant Protein Sales in Volume by Application (2017-2028)
6.2 Global Prokaryotic Recombinant Protein Revenue by Application (2017-2028)
6.3 Global Prokaryotic Recombinant Protein Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Prokaryotic Recombinant Protein Sales by Type (2017-2028)
7.2 North America Prokaryotic Recombinant Protein Sales by Application (2017-2028)
7.3 North America Prokaryotic Recombinant Protein Market Size by Country
7.3.1 North America Prokaryotic Recombinant Protein Sales in Volume by Country (2017-2028)
7.3.2 North America Prokaryotic Recombinant Protein Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Prokaryotic Recombinant Protein Sales by Type (2017-2028)
8.2 Europe Prokaryotic Recombinant Protein Sales by Application (2017-2028)
8.3 Europe Prokaryotic Recombinant Protein Market Size by Country
8.3.1 Europe Prokaryotic Recombinant Protein Sales in Volume by Country (2017-2028)
8.3.2 Europe Prokaryotic Recombinant Protein Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Prokaryotic Recombinant Protein Sales by Type (2017-2028)
9.2 Asia-Pacific Prokaryotic Recombinant Protein Sales by Application (2017-2028)
9.3 Asia-Pacific Prokaryotic Recombinant Protein Market Size by Region
9.3.1 Asia-Pacific Prokaryotic Recombinant Protein Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Prokaryotic Recombinant Protein Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Prokaryotic Recombinant Protein Sales by Type (2017-2028)
10.2 South America Prokaryotic Recombinant Protein Sales by Application (2017-2028)
10.3 South America Prokaryotic Recombinant Protein Market Size by Country
10.3.1 South America Prokaryotic Recombinant Protein Sales in Volume by Country (2017-2028)
10.3.2 South America Prokaryotic Recombinant Protein Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Prokaryotic Recombinant Protein Sales by Type (2017-2028)
11.2 Middle East & Africa Prokaryotic Recombinant Protein Sales by Application (2017-2028)
11.3 Middle East & Africa Prokaryotic Recombinant Protein Market Size by Country
11.3.1 Middle East & Africa Prokaryotic Recombinant Protein Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Prokaryotic Recombinant Protein Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Prokaryotic Recombinant Protein and Key Manufacturers
12.2 Manufacturing Costs Percentage of Prokaryotic Recombinant Protein
12.3 Prokaryotic Recombinant Protein Production Process
12.4 Prokaryotic Recombinant Protein Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Prokaryotic Recombinant Protein Typical Distributors
13.3 Prokaryotic Recombinant Protein Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer

---